Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 494

1.

In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias.

Gautier P, Serre M, Cosnier-Pucheu S, Djandjighian L, Roccon A, Herbert JM, Nisato D.

J Cardiovasc Pharmacol. 2005 Feb;45(2):125-35.

PMID:
15654261
[PubMed - indexed for MEDLINE]
2.

In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects.

Gautier P, Guillemare E, Djandjighian L, Marion A, Planchenault J, Bernhart C, Herbert JM, Nisato D.

J Cardiovasc Pharmacol. 2004 Aug;44(2):244-57.

PMID:
15243307
[PubMed - indexed for MEDLINE]
3.

Class III antiarrhythmic action in experimental atrial fibrillation and flutter in dogs.

Platou ES, Refsum H.

J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):839-46.

PMID:
6182417
[PubMed - indexed for MEDLINE]
4.

SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.

Manning AS, Bruyninckx C, Ramboux J, Chatelain P.

J Cardiovasc Pharmacol. 1995 Sep;26(3):453-61.

PMID:
8583788
[PubMed - indexed for MEDLINE]
6.

Effects of a new class III antiarrhythmic drug nibentan in a canine model of vagally mediated atrial fibrillation.

Fedorov VV, Sharifov OF, Beloshapko GG, Yushmanova AV, Rosenshtraukh LV.

J Cardiovasc Pharmacol. 2000 Jul;36(1):77-89.

PMID:
10892664
[PubMed - indexed for MEDLINE]
7.

Effects of a novel amiodarone-like compound SAR114646A on the pig atrium and susceptibility to ventricular fibrillation in dogs and pigs.

Billman GE, Gögelein H, Ruetten H, Wirth KJ.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Apr;385(4):373-84. doi: 10.1007/s00210-011-0716-9. Epub 2012 Jan 11.

PMID:
22234329
[PubMed - indexed for MEDLINE]
8.

Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter.

Nagasawa H, Fujiki A, Fujikura N, Matsuda T, Yamashita T, Inoue H.

Circ J. 2002 Feb;66(2):185-91.

PMID:
11999646
[PubMed - indexed for MEDLINE]
Free Article
9.

[Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].

Borchard R, van Bracht M, Wickenbrock I, Prull MW, Pott L, Trappe HJ.

Med Klin (Munich). 2005 Nov 15;100(11):697-703. German.

PMID:
16328176
[PubMed - indexed for MEDLINE]
10.

Antiarrhythmic effects of HOE642, a novel Na(+)-H+ exchange inhibitor, on ventricular arrhythmias in animal hearts.

Xue YX, Aye NN, Hashimoto K.

Eur J Pharmacol. 1996 Dec 19;317(2-3):309-16.

PMID:
8997615
[PubMed - indexed for MEDLINE]
11.

Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.

Hashimoto N, Yamashita T, Tsuruzoe N.

J Cardiovasc Pharmacol. 2008 Feb;51(2):162-9. doi: 10.1097/FJC.0b013e31815e854c.

PMID:
18287884
[PubMed - indexed for MEDLINE]
12.

Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates.

Comtois P, Sakabe M, Vigmond EJ, Munoz M, Texier A, Shiroshita-Takeshita A, Nattel S.

Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1489-504. doi: 10.1152/ajpheart.01054.2007. Epub 2008 Aug 1.

PMID:
18676686
[PubMed - indexed for MEDLINE]
Free Article
13.

Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation.

Diness JG, Sørensen US, Nissen JD, Al-Shahib B, Jespersen T, Grunnet M, Hansen RS.

Circ Arrhythm Electrophysiol. 2010 Aug;3(4):380-90. doi: 10.1161/CIRCEP.110.957407. Epub 2010 Jun 19.

PMID:
20562443
[PubMed - indexed for MEDLINE]
Free Article
14.

The novel antiarrhythmic drug dronedarone: comparison with amiodarone.

Kathofer S, Thomas D, Karle CA.

Cardiovasc Drug Rev. 2005 Fall;23(3):217-30. Review.

PMID:
16252015
[PubMed - indexed for MEDLINE]
15.

Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats.

Goegelein H, Gautier P, Roccon A, O'Connor S, Ruetten H.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Sep;384(3):231-44. doi: 10.1007/s00210-011-0664-4. Epub 2011 Jul 16.

PMID:
21766160
[PubMed - indexed for MEDLINE]
16.
17.

Dronedarone: a new antiarrhythmic agent.

Zareba KM.

Drugs Today (Barc). 2006 Feb;42(2):75-86.

PMID:
16541184
[PubMed - indexed for MEDLINE]
19.

Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia.

Kamiya J, Ishii M, Katakami T.

Jpn J Pharmacol. 1992 Feb;58(2):107-15.

PMID:
1507517
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk